Two new diabetes drugs together versus alone for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether combining two new medications (DWP16001 and DWC202518) works better than taking either one alone for controlling type 2 diabetes. You'll be randomly assigned to one of three groups and monitored for safety and how well your blood sugar is controlled.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes diagnosed by standard guidelines
- Your blood sugar control (HbA1c) is between 7.5–11% or 6.5–10.5% depending on your current medications
- You have either never taken oral diabetes pills or stopped them at least 12 weeks ago (or are on exactly one type)
- Your body mass index (BMI) is between 20 and 45 kg/m²
- You have no severe diabetes complications like advanced eye, kidney, or nerve damage
- You agree to use reliable birth control if you can become pregnant, and to not donate sperm if you are male
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three diabetes medicines (henagliflozin, retagliptin, and extended-release metformin) to see if they are safe and effective for Chinese adults with type 2 diabetes. You may join if you are newly diagnosed or have been taking one oral diabetes pill but need better blood sugar control.
This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.
This study tests how well a new combination diabetes medication (chiglitazar/metformin) works in the body compared to taking the two drugs separately. It is for healthy volunteers and helps ensure the new pill is safe and effective.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests whether taking two separate blood pressure medications work as well as taking them combined in one pill for people with high blood pressure and type 2 diabetes. The goal is to find the best, safest way to treat both conditions together.
This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.
Hear when a new T2DM (Type 2 Diabetes Mellitus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.